Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-Dependent pathway in esophageal cancer cells

International Journal of Cancer

Volumn 93, Issue 2, 2001, Pages 218-223

  Li, Ming ^a   Wu, Xiuyuan ^a   Xu, Xiao Chun ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b Department of Clinical Cancer Prevention 236 ^*  (United States)

Author keywords

Apoptosis; Cyclo oxygenase; Cytochrome c; Esophageal cancer; Non steroidal anti inflammatory drugs

Indexed keywords

CASPASE 3; CASPASE 9; CASPASE INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHROME C; DNA FRAGMENT; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CARCINOGENESIS; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL;

APOPTOSIS; CASPASES; CELL SURVIVAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; CYTOCHROME C GROUP; DINOPROSTONE; DRUG INTERACTIONS; ENZYME ACTIVATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MITOCHONDRIA; NITROBENZENES; POLY(ADP-RIBOSE) POLYMERASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEINS; SULFONAMIDES; TUMOR CELLS, CULTURED;

EID: 0035879809     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1322     Document Type: Article

References (33)

1. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: Independence from COX-2 protein expression
2. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398
3. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer
4. Aspirin and reduced risk of esophageal carcinoma
5. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
6. Aspirin induction of apoptosis in esophageal cancer: A potential for chemoprevention
7. Colorectal cancer and nonsteroidal anti-inflammatory drugs
8. Cyclooxygenase-2 inhibitors in tumorigenesis (part I)
9. Cyclooxygenase-2 inhibitors in tumorigenesis (part II)
10. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
11. Antitumoral activity of indomethacin on experimental esophageal tumors
12. Further studies on the therapeutic effect of indomethacin on esophageal tumors
13. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells
14. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398
15. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas
16. Cyclooxygenase-2 expression in human esophageal carcinoma
17. Apoptosis
18. Mitochondria as regulators of apoptosis: Doubt no more
19. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells
20. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
21. Cytochrome c release from mitochondria: All or nothing
22. Mitochondria and apoptosis
23. Nonsteroidal anti-inflammatory drugs and cancer prevention
24. Bcl-2 family: Life-or-death switch
25. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
26. Mitochondrial control of cell death
27. Induction of mitochondrial permeability transition and cytochrome c release in the absence of caspase activation is insufficient for effective apoptosis in human leukemia cells
28. Aspirin and the potential role of prostaglandins in colon cancer
29. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs
30. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction
31. 15-LOX-1: A novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells
32. Intracellular unesterified arachidonic acid signals apoptosis
33. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs